BRIEF published on 10/24/2025 at 09:41, 4 months 28 days ago JP Morgan Chase & Co. Franchit le Seuil de 5% chez ABIVAX Capital Droits De Vote Abivax Franchissement De Seuils JP Morgan
PRESS RELEASE published on 10/24/2025 at 09:36, 4 months 28 days ago Franchissement de seuils Déclaration de franchissement de seuils par JP Morgan Chase & Co. concernant ABIVAX sur Euronext Paris le 23 octobre 2025 Euronext Paris Abivax Actionnariat Franchissement De Seuils JP Morgan Chase & Co.
BRIEF published on 10/15/2025 at 18:05, 5 months 6 days ago ABIVAX : État des actions et droits de vote au 30 septembre 2025 Droits De Vote Euronext Capital Social Biotechnologie Abivax
BRIEF published on 10/15/2025 at 18:05, 5 months 6 days ago ABIVAX: Status of shares and voting rights as of September 30, 2025 Share Capital Voting Rights Biotechnology Euronext Abivax
PRESS RELEASE published on 10/15/2025 at 18:00, 5 months 6 days ago ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 30.09.25 ABIVAX communique sur le nombre d'actions et droits de vote au 30/09/2025 conformément aux réglementations de l'AMF. Abivax est une société biotechnologique en développement clinique Capital Social Biotechnologie Abivax Droit De Vote Régulation Immunitaire
BRIEF published on 10/13/2025 at 14:50, 5 months 8 days ago JP Morgan dépasse le seuil de 5% chez ABIVAX Droits De Vote Franchissement De Seuil Actions Abivax JP Morgan
BRIEF published on 10/13/2025 at 14:50, 5 months 8 days ago JP Morgan exceeds the 5% threshold at ABIVAX Voting Rights Actions Abivax Threshold Crossing JP Morgan
PRESS RELEASE published on 10/13/2025 at 14:45, 5 months 8 days ago Franchissement de seuil Déclaration de franchissement de seuil par JP Morgan Chase & Co. pour ABIVAX sur Euronext Paris Euronext Paris Déclaration Franchissement De Seuil Abivax JP Morgan Chase & Co.
BRIEF published on 10/06/2025 at 10:05, 5 months 15 days ago Abivax Dévoile Nouveaux Résultats Prometteurs d'Obefazimod Abivax Obefazimod Résultats Rectocolite Hémorragique Essai Clinique
BRIEF published on 10/06/2025 at 10:05, 5 months 15 days ago Abivax Unveils Promising New Results from Obefazimod Abivax Obefazimod Ulcerative Colitis Clinical Trial Results
Published on 03/20/2026 at 13:30, 1 day 15 hours ago Unusual Machines Announces Pricing of Approximately $150 Million Public Offering of Common Stock
Published on 03/20/2026 at 12:30, 1 day 16 hours ago CANEX Metals Announces the Numbers of Gold Basin Shares Taken up by Canex Metals
Published on 03/20/2026 at 22:45, 1 day 5 hours ago Investor Alert: Berger Montague (Canada) PC represents investors that purchased shares of Super Micro Computer, Inc. listed on the CBOE Canada and elsewhere
Published on 03/20/2026 at 21:05, 1 day 7 hours ago Fractal EMS Receives ISO/IEC 9001 and 27001 Certifications
Published on 03/20/2026 at 21:05, 1 day 7 hours ago Nebius Group announces closing of private offering of convertible senior notes, with aggregate gross proceeds of approximately $4.3 billion
Published on 03/20/2026 at 21:00, 1 day 7 hours ago BRP Unveils the Winners of its 6th International Design Challenge
Published on 03/20/2026 at 20:05, 1 day 8 hours ago INVESTOR ALERT: Goeasy Ltd. Shareholder Class Action
Published on 03/20/2026 at 19:00, 1 day 9 hours ago AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 1 day 9 hours ago AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 1 day 10 hours ago Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 1 day 10 hours ago Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA
